title: Protective effect of serum antibody on respiratory infection of influenza C virus in rats.
abstract: The effects of serum antibody on the replication of influenza C virus in the nose and lung were evaluated in rats challenged with the virus by the intranasal and endotracheal routes, respectively. Convalescent rat serum administered intraperitoneally prior to infection suppressed virus replication significantly in both the nasal and pulmonary tissues. Resistance achieved was however much greater in the lung than in the nose. Rats with a serum neutralizing antibody titer of 1:800 showed almost complete resistance to pulmonary virus infection, and virus yield from the lung was reduced 10- to 100-fold in animals with the antibody titer of 1:80-160 or less. In contrast, significant decrease in virus shedding from the nose was observed only in animals with a serum antibody titer of 1:800 or greater. The effect of adoptive transfer of monoclonal antibodies (MAbs) to haemagglutinin-esterase (HE) glycoprotein and matrix (M) protein on pulmonary virus replication was also examined. Anti-HE MAbs with neutralization activity prevented virus shedding from the lung almost completely whereas non-neutralizing anti-HE MAb and anti-M Mab showed no inhibitory effect.
authors.affiliation: Laboratory Animal Center, Yamagata University School of Medicine, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takiguchi
authors.forename: K
authors.initials: K
authors.lastname: Sugawara
authors.forename: S
authors.initials: S
authors.lastname: Hongo
authors.forename: H
authors.initials: H
authors.lastname: Nishimura
authors.forename: F
authors.initials: F
authors.lastname: Kitame
authors.forename: K
authors.initials: K
authors.lastname: Nakamura
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology; D000914:Antibodies, Viral / Q000008:administration & dosage*; D005260:Female; D006389:Hemagglutinins, Viral / Q000276:immunology; D007116:Immunization, Passive; D009982:Gammainfluenzavirus / Q000276:immunology; D008168:Lung / Q000382:microbiology; D008297:Male; D009500:Neutralization Tests; D009666:Nose / Q000382:microbiology; D009976:Orthomyxoviridae Infections / Q000382:microbiology / Q000517:prevention & control*; D051381:Rats; D014760:Viral Fusion Proteins; D014763:Viral Matrix Proteins / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology; D014779:Virus Replication
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D006389:Hemagglutinins, Viral; C031540:M-protein, influenza virus; D014760:Viral Fusion Proteins; D014763:Viral Matrix Proteins; D014764:Viral Proteins; C060814:hemagglutinin esterase